Creative Planning - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 16.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,693
-64.7%
11,753
+17.5%
0.00%
Q3 2021$36,000
-16.3%
10,0000.0%0.00%
Q2 2021$43,000
-37.7%
10,000
-50.5%
0.00%
Q1 2021$69,000
+91.7%
20,200
+98.0%
0.00%
Q4 2020$36,000
-25.0%
10,200
-49.5%
0.00%
Q3 2020$48,000
+29.7%
20,2000.0%0.00%
Q2 2020$37,000
+19.4%
20,200
+1.0%
0.00%
Q1 2020$31,000
-27.9%
20,0000.0%0.00%
Q4 2019$43,000
+16.2%
20,0000.0%0.00%
Q3 2019$37,000
-28.8%
20,0000.0%0.00%
Q2 2019$52,000
+2.0%
20,0000.0%0.00%
Q1 2019$51,000
+10.9%
20,0000.0%0.00%
Q4 2018$46,000
-28.1%
20,0000.0%0.00%
Q3 2018$64,000
+128.6%
20,000
+100.0%
0.00%
Q2 2018$28,000
-20.0%
10,0000.0%0.00%
Q1 2018$35,000
-18.6%
10,000
-9.1%
0.00%
Q4 2017$43,000
+72.0%
11,000
+10.0%
0.00%
Q3 2017$25,000
-10.7%
10,000
-3.0%
0.00%
Q2 2017$28,000
-15.2%
10,309
+3.1%
0.00%
Q1 2017$33,000
+37.5%
10,0000.0%0.00%
Q4 2016$24,000
-35.1%
10,0000.0%0.00%
Q3 2016$37,000
+68.2%
10,0000.0%0.00%
Q2 2016$22,000
+4.8%
10,0000.0%0.00%
Q1 2016$21,000
-50.0%
10,000
-28.6%
0.00%
Q4 2015$42,000
+68.0%
14,000
+40.0%
0.00%
Q3 2015$25,000
-21.9%
10,0000.0%0.00%
Q2 2015$32,000
-11.1%
10,0000.0%0.00%
Q1 2015$36,000
+3500.0%
10,000
+1462.5%
0.00%
Q3 2014$1,0006400.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders